BIAF
Bioaffinity Technologies
$0.68
+$0.02 (+3.33%)Jul 27, 2026
Key metrics
The numbers that frame BIAF today
- Market cap
- $3.09M
- P/E (TTM)
- -0.2
- EV / FCF
- -0.1
- Gross margin
- 33.1%
- EV / Sales
- 0.2
- ROIC
- -4,146.4%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $0.61
- 52wk High
- $13.50
Growth
Revenue and earnings trend for BIAF
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BIAF
Is Bioaffinity Technologies a good buy?
No. Bioaffinity Technologies has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Bioaffinity Technologies is selling at a very high price.
What is the market capitalization of BIAF?
Bioaffinity Technologies's market capitalization is $3.09M.
What is the P/E ratio for BIAF stock?
Bioaffinity Technologies's current P/E ratio is -0.2.
What is the 52-week high for BIAF stock?
The 52-week high for Bioaffinity Technologies is $13.50. The current close of $0.68 is 94.9% below that high.
What is the 52-week low for BIAF stock?
The 52-week low for Bioaffinity Technologies is $0.61. The current close of $0.68 is 11.4% above that low.
Does BIAF stock pay dividends?
Bioaffinity Technologies does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BIAF?
Bioaffinity Technologies's Debt / Equity ratio is 0.38.